Please assess the completion status of the following clinical trial:

Trial Title: Oral/Intramuscular B12 to Treat Cobalamin Deficiency

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ≥ 65 aged patients with Cobalamin Deficiency.~* Patients give inform consent.~Exclusion Criteria:~* Treatment with B12 (1 last year)~* Neurologic or psychiatric pathologies~* Folic acid \< 2.3ng/ml ...

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- oral Cobalamin (vitamin B12) (Type: EXPERIMENTAL): oral Cobalamin (vitamin B12)
- intramuscular Cobalamin (vitamin B12) (Type: EXPERIMENTAL): intramuscular Cobalamin (vitamin B12)

Based on this trial design, predict the completion outcome and termination type (if applicable).